salt form is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-10-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Routine characterisation relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres, using a C18 column and a water-acetonitrile gradient containing trifluoroacetic acid. Electrospray ionisation mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidised by-products that co-elute poorly. Sequence and stereochemistry require additional work, such as peptide mapping or amino acid analysis, because a chromatographic purity figure alone does not distinguish a diastereomer from the target peptide. Independent testing of research-grade material frequently shows measured content below the stated label, so a certificate of analysis is best read together with the method that produced it.
Melanotan-2 is handled in the laboratory as a lyophilised powder that dissolves readily in water, dimethyl sulfoxide and dimethylformamide, with limited solubility in ethanol. Stock solutions prepared in an organic solvent often precipitate when diluted into aqueous buffer, so gradual dilution with mixing is standard practice. The peptide carries a tryptophan residue and a histidine residue, both sensitive to oxidation and to alkaline conditions. Working solutions are therefore kept near neutral to slightly acidic pH, protected from light, and consumed within the same working session whenever that is practical.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
==== Chorion ==== The chorionic membrane is a fibrous tissue layer containing the fetal blood vessels. Chorionic villi form on the outer surface of the chorion, which maximise surface area for contact with maternal blood. The chorionic villi are involved in fetal-maternal exchange.
==== DP_PWR (pin 20) ==== Pin 20 on the DisplayPort connector, called DP_PWR, provides 3.3 V (±10%) DC power at up to 500 mA (minimum power delivery of 1.5 W). This power is available from all DisplayPort receptacles, on both source and display devices. DP_PWR is intended to provide power for adapters, amplified cables, and similar devices, so that a separate power cable is not necessary. Standard DisplayPort cable connections do not use the DP_PWR pin. Connecting the DP_PWR pins of two devices directly together through a cable can create a short circuit which can potentially damage devices, since the DP_PWR pins on two devices are unlikely to have exactly the same voltage (especially with a ±10% tolerance). For this reason, the DisplayPort 1.1 and later standards specify that passive DisplayPort-to-DisplayPort cables must leave pin 20 unconnected. However, in 2013 VESA announced that after investigating reports of malfunctioning DisplayPort devices, it had discovered that a large number of non-certified vendors were manufacturing their DisplayPort cables with the DP_PWR pin connected:
==== Metabolism ==== In terms of metabolism, methenamine is hydrolyzed to form formaldehyde and ammonium in acidic urine (pH < 6). More specifically, a single molecule of methenamine decomposes into six equivalents of formaldehyde and four ammonia molecules. The drug may be degraded 10 to 30% in the acidic environment of the stomach prior to absorption. This can be avoided with enteric coated tablets. In terms of pH, there is minimal hydrolysis at a pH of 7.4, 6% at a pH of 6, and 20% at a pH of 5. The hydrolysis of methenamine occurs slowly and gradually, with approximately 3 hours required for 90% decomposition into formaldehyde. As breakdown of methenamine only occurs in acidic environments like the bladder and stomach, the activation of methenamine into formaldehyde in the body is tissue-selective. Following its formation, formaldehyde is rapidly metabolized into formic acid (formate) in the body.
=== Tandem nursing === A mother can continue breastfeeding an older sibling while also breastfeeding a new baby; this is called tandem nursing. During the late stages of pregnancy, the milk changes to colostrum. While some children continue to breastfeed even with this change, others may wean. Most mothers can produce enough milk for tandem nursing, but the new baby should be nursed first for at least the first few days after delivery to ensure it receives enough colostrum. Breastfeeding triplets or larger broods is a challenge given babies' varying appetites. Breasts can respond to the demand and produce larger milk quantities; mothers have breastfed triplets successfully.
Sources: en.wikipedia.org
=== Implementing agencies === Bureau of Industry and Security Directorate of Defense Trade Controls Office of Foreign Assets Control U.S. Customs and Border Protection United States Department of Commerce (Export Administration Regulations, EAR) United States Department of Defense United States Department of Energy (nuclear technology) United States Department of Homeland Security (border crossings) United States Department of Justice (including ATF and FBI) United States Department of State (International Traffic in Arms Regulations, ITAR) United States Department of the Treasury
The strength and direction of these fields are the same regardless of the size of a wound. Healing of skin wounds is a complex process involving the cooperation of various elements of the body, such as platelets, immune cells, epithelial cells, and fibroblasts. This process is coordinated largely by chemical signals, but there is evidence that electrotaxis plays an additional role in directing specific cell types toward the site of an injury. During the proliferation phase of recovery, keratinocytes move toward the cathodal side of the EFs occurring around and injury, bringing them toward the edge of the wound. In fact, in vitro experimentation found that application of physiological strength EFs could override other signals and guide cells to migrate towards or even away from a wound depending on the direction of the field, regardless of chemical factors. EFs have also experimentally been found to influence cell migration in human umbilical vein cells, dermal fibroblasts, and myofibroblasts.
Estrogen promotes cellular development and prevents programmed cell death (apoptosis) via activating specific pathways mediated by estrogen receptors (ER) in various types of cells. Estrogen promotes the development of breast cancers that have estrogen receptor (ER) by stimulating the proliferation and survival of breast cancer cells. Estrogen receptor (ER) is a significant indicator for predicting outcomes and guiding treatment decisions, and it is found in around 75% of breast cancers. Estrogen triggers apoptosis in breast cancer cells as well as other types of cells. Receptor levels rise as individuals age among certain ethnic groups, and typically, white women have greater receptor levels compared to black or Japanese women. It has been hypothesized that the absence of a tumor-suppressor gene may lead to the inability to decrease the activity of estrogen receptors when cells enter the cell cycle or the inability to inhibit the division of cells that have estrogen receptors. This might potentially be a mechanism for the development of breast cancer.
The physical properties of honey vary, depending on water content, the type of flora used to produce it (pasturage), temperature, and the proportion of the specific sugars it contains. Fresh honey is a supersaturated liquid, containing more sugar than the water can typically dissolve at ambient temperatures. At room temperature, honey is a supercooled liquid, in which the glucose precipitates into solid granules. This forms a semisolid solution of precipitated glucose crystals in a solution of fructose and other ingredients. The density of honey typically ranges between 1.38 and 1.45 kg/L at 20 °C (68 °F).
=== Benefits to females === Among numerous species in the animal kingdom, females may benefit from absorbing nutrients and proteins from seminal fluid for food, antiviral and antibacterial properties, and enhanced fertilisation. In humans, seminal fluid provides anti-viral activity towards herpes simplex virus and can transfer anti-microbial peptides cathelicidin and lactoferrin. In birds and mammals, mutualistic bacteria such as Lactobacillus have been detected in fluid transferral. A study on the effect of semen in male-to-female transmission of HIV, in both humans and non-human primates (rhesus macaques), noted that regular intravaginal exposure to a healthy male's semen modulates the microenvironment in the female reproductive tract (FRT), and, paradoxically, improves the resistance in females against acquiring HIV by activating their bodies' anti-HIV mechanisms.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
The dry powder is more stable during transport and storage than a solution. It also allows a known amount of material to be reconstituted at a chosen concentration.